Institutional investors purchased a net $19.3 million shares of OPK during the quarter ended September 2015. This may signal that the smart money is gaining interest in this company as the 23.50% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIRST TRUST ADVISORS LP Bought 4.3 Million shares of OPKO Health Inc
DEUTSCHE INVESTMENT MANAGEMENT A... Bought 2.0 Million shares of OPKO Health Inc
AMITIM SENIOR PENSION FUNDS Bought 2.0 Million shares of OPKO Health Inc